BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15984528)

  • 1. [TS-1 treatment for progressive gastric cancer in a patient on chronic dialysis--assessment of dosage regimen by monitoring blood concentrations of therapeutic drugs (TDM)].
    Tanaka T; Fujita S; Tanaka N; Ooka M; Okajima S; Tanaka N
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):841-5. PubMed ID: 15984528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A trial of TS-1 administration on the basis of the pharmacokinetic study for an advanced gastric cancer patient with impaired renal function].
    Yamamoto K; Imamura H; Furukawa H; Kishimoto T; Tanaka J; Oshiro R; Tatsuta M; Masutani S; Fukunaga M; Nakayama T; Takemoto H; Kondo M; Kamigaki S; Kawasaki T
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1748-51. PubMed ID: 16315929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of S-1, a novel oral fluorouracil antitumor drug, for a chronic renal failure patient maintained on hemodialysis.
    Tominaga K; Higuchi K; Okazaki H; Suto R; Hamaguchi M; Tanigawa T; Sasaki E; Shiba M; Watanabe T; Fujiwara Y; Oshitani N; Matsumoto T; Arakawa T
    Oncology; 2004; 66(5):358-64. PubMed ID: 15331922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Concentration of FT and CDHP and 5-FU in the ascites fluid of patient with peritoneal carcinomatosis after new anti-cancer drug TS-1 oral administration].
    Iizuka R; Takahashi S; Kakihara N; Matsumura H; Takenaka A
    Gan To Kagaku Ryoho; 2002 Jul; 29(7):1251-3. PubMed ID: 12146009
    [No Abstract]   [Full Text] [Related]  

  • 5. Alternate-day oral therapy with TS-1 for advanced gastric cancer.
    Arai W; Hosoya Y; Hyodo M; Yokoyama T; Hirashima Y; Yasuda Y; Nagai H; Shirasaka T
    Int J Clin Oncol; 2004 Jun; 9(3):143-8. PubMed ID: 15221596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of type 4 gastric cancer with peritoneal dissemination successfully treated over 2 years by alternate-day administration of TS-1].
    Arai W; Hosoya Y; Yokoyama T; Saito S; Hirashima Y; Hyodo M; Yasuda Y; Nagai H; Shirasaka T
    Gan To Kagaku Ryoho; 2004 Feb; 31(2):237-40. PubMed ID: 14997759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of gastrectomy on the pharmacokinetics of 5-fluorouracil and gimeracil after oral administration of S-1.
    Tsuruoka Y; Kamano T; Kitajima M; Kawai K; Watabe S; Ochiai T; Sakamoto K; Shirasaka T
    Anticancer Drugs; 2006 Apr; 17(4):393-9. PubMed ID: 16549996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gastric cancer with multiple liver metastases, which responded significantly to oral administration of TS-1 following intravenous FMP therapy under hospitalization].
    Tasaka K; Okada Y; Tomofuji Y; Chinzei T
    Gan To Kagaku Ryoho; 2002 Sep; 29(9):1631-5. PubMed ID: 12355951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of pre-operative administration of TS-1 in patients with advanced gastric or colorectal cancer--estimation of pathological effectiveness for postoperative adjuvant chemotherapy with TS-1].
    Nakano K; Koizumi H; Okugawa K; Nakamura K; Osaka Y; Tsuchiya K; Sako H; Tanabe S; Nakane Y
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):329-33. PubMed ID: 15791815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I and pharmacokinetic study of the oral fluoropyrimidine S-1 on a once-daily-for-28-day schedule in patients with advanced malignancies.
    Chu QS; Hammond LA; Schwartz G; Ochoa L; Rha SY; Denis L; Molpus K; Roedig B; Letrent SP; Damle B; DeCillis AP; Rowinsky EK
    Clin Cancer Res; 2004 Aug; 10(15):4913-21. PubMed ID: 15297391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of advanced gastric cancer resected after successful treatment with the novel oral anticancer drug TS-1].
    Koyama M; Inaba Y; Watabe S; Hayashi K; Tsuge T; Kamio Y; Chiba M; Tamura M
    Gan To Kagaku Ryoho; 2003 Apr; 30(4):531-5. PubMed ID: 12722688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case report of adjuvant chemotherapy (TS-1) for far advanced gastric cancer in which the patient maintained a good quality of life].
    Omoto Y; Sekiguchi C; Hyodo M; Ohdaira T; Kumano H; Ohtuka S
    Gan To Kagaku Ryoho; 2003 Mar; 30(3):399-402. PubMed ID: 12669400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of TS-1 in patients with peritonitis carcinomatosa from gastric cancer].
    Nakagawa A; Ichiki M; Sai K; Sugawara H
    Gan To Kagaku Ryoho; 2003 Oct; 30(10):1501-3. PubMed ID: 14584285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of advanced gastric cancer effectively treated by TS-1 for 4 years].
    Ogino H; Misawa T; Nasu T; Ihara Y; Kubo S; Sadamoto Y; Harada N; Nakamura K
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):833-6. PubMed ID: 15984526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral fluoropyrimidine anticancer drug TS-1 for gastric cancer patients with peritoneal dissemination.
    Osugi H; Takada N; Takemura M; Kaseno S; Lee S; Ueno M; Tanaka Y; Fukuhara K; Fujiwara Y; Kinoshita H
    Oncol Rep; 2002; 9(4):811-5. PubMed ID: 12066214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Remnant gastric cancer in which prolonged no change status was maintained with low-dose TS-1--a case report].
    Takemura M; Osugi H; Lee S; Taguchi S; Kaneko M; Tanaka Y; Fukuhara K; Fujiwara Y; Nishizawa S; Kinoshita H
    Gan To Kagaku Ryoho; 2003 May; 30(5):695-8. PubMed ID: 12795104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of an elderly patient with gastric cancer successfully treated with TS-1 considering impaired renal function caused by aging].
    Kishimoto T; Imamura H; Furukawa H; Yamamoto K; Miyazaki Y; Ohshiro R; Ohta K; Nakata Y; Kamigaki S; Kondo M; Takemoto H; Fujimi S; Nakayama T; Fukunaga M; Ohsato H; Tatsuta M
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1891-3. PubMed ID: 17212138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of lymph node recurrence after curative operation of type 4 gastric cancer, successfully treated with TS-1].
    Yamamoto K; Imamura H; Furukawa H; Kato H; Esumi K; Masuda N; Shimizu J; Ishida H; Masutani S; Tatsuta M; Kawasaki T
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1833-5. PubMed ID: 14619532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Examination of the feasibility of TS-1 for postoperative advance stomach cancer patients].
    Hara A; Tokuhara T; Takahashi Y; Izumi N; Iwamoto S; Satake K
    Gan To Kagaku Ryoho; 2004 Apr; 31(4):601-4. PubMed ID: 15114708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of CA19-9 producing gastric cancer treated by low-dose administration of TS-1 for adjuvant chemotherapy].
    Takashima I; Seto Y; Nagamine I; Kegoya Y; Kodoi A; Nakayama H
    Gan To Kagaku Ryoho; 2005 Apr; 32(4):503-5. PubMed ID: 15853217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.